NAMS logo

NAMSNewAmsterdam Pharma Company NV

$30.65
$0.39
(1.29%)
Today
Updated: 01:03 PM EDT
EarningsAug 5
Mkt Cap$3.54B
Vol302,900.00

About

NewAmsterdam Pharma Co. NV is a clinical-stage biopharmaceutical company, which engages in the development of oral, non-statin medicine for patients at high risk of cardiovascular disease with residual elevation of low-density lipoprotein cholesterol. Its lead product candidate, Obicetrapib, is a next-generation, oral, low-dose cholesteryl ester transfer protein inhibitor, which will be used to prevent major adverse cardiovascular events. The company was founded on June 10, 2022 and is headquartered in Naarden, the Netherlands.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
100

Frequently Asked Questions

What is Market Cap of NewAmsterdam Pharma Company NV?
What is the 52-week high for NewAmsterdam Pharma Company NV?
What is the 52-week low for NewAmsterdam Pharma Company NV?
What is NewAmsterdam Pharma Company NV stock price today?
What was NewAmsterdam Pharma Company NV stock price yesterday?
What is the PE ratio of NewAmsterdam Pharma Company NV?
What is the Price-to-Book ratio of NewAmsterdam Pharma Company NV?
What is the 50-day moving average of NewAmsterdam Pharma Company NV?
How many employees does NewAmsterdam Pharma Company NV have?